| Last Trade On | Aug 25, 2026 | Day's Range | Rs 88.01 - 90.40 |
|---|---|---|---|
| Change | Rs 0.77 | 52 Week Range | Rs 76.37 - 137.44 |
| Open | Rs 88.01 | Volume | 5,305,167 |
| Close | Rs 88.78 | Previous Close | Rs 88.78 |
| Period | High | Low | Volume / Average |
|---|---|---|---|
| 1M | 92.20 | 87.67 | 30,826,985.00; Avg 1,541,349.25 |
| 3M | 99.16 | 87.67 | 168,510,008.00; Avg 2,808,500.13 |
| 6M | 99.16 | 76.37 | 373,320,723.00; Avg 3,163,734.94 |
| 1Y | 135.07 | 76.37 | 1,277,924,249.00; Avg 5,152,920.36 |
| Financial Year | 2025 | O/S Shares | 511.49m |
|---|---|---|---|
| Net Profit | Rs 434.04m | Market Cap | Rs 45,410.48m |
| EPS | 0.85 | P/E | 104.62 |
| Par Value | Rs 10.00 | Book Value | 59.12 |
| Net Worth | Rs 30,239.68m | Outstanding Shares | 511.49m |
| Dividend | Rs 0.00 | ROE | 1.44% |
| Dividend Yield | 0.00% | Dividend Payout | 0.00% |
| Earnings Yield | 0.96% | Sharia Compliant | No |
No upcoming meetings scheduled for SEARL.
Yasir Mahmood Securities has partnered with TradingView for its charting solution.
A comprehensive trading platform which offers intuitive analytical tools,
stock screener and
real time economic calendar data
to track key financial events.
| Year | Individual | Institutions | Investment Companies | Foreign Investors | Government | Shareholders | Other |
|---|---|---|---|---|---|---|---|
| 2025 | 26.57% | 4.01% | 50.65% | 6.58% | 0.00% | 21,458.00 | 8.58% |
| 2024 | 27.08% | 5.02% | 50.66% | 4.67% | 0.00% | 18,334.00 | 9.13% |
| 2023 | 22.26% | 4.87% | 53.43% | 4.26% | 0.00% | 17,470.00 | 6.35% |
| 2022 | 18.27% | 3.21% | 54.71% | 7.38% | 0.00% | 14,515.00 | 12.33% |
| 2021 | 15.50% | 1.77% | 54.70% | 9.25% | 0.00% | 11,040.00 | 15.38% |
| 2020 | 17.97% | 4.60% | 57.20% | 8.13% | 0.00% | 12,592.00 | 5.49% |
| 2019 | 17.27% | 6.25% | 57.23% | 8.43% | 0.00% | 11,985.00 | 4.91% |
| 2018 | 15.98% | 6.20% | 57.23% | 9.90% | 0.00% | 10,568.00 | 4.04% |
| 2017 | 15.08% | 5.40% | 56.78% | 10.48% | 0.00% | 9,586.00 | 2.67% |
| 2016 | 70.76% | 6.78% | 0.00% | 12.31% | 0.00% | 7,343.00 | 2.03% |
| 2015 | 15.58% | 5.25% | 57.17% | 12.59% | 0.00% | 6,248.00 | 2.93% |
| 2014 | 18.64% | 6.31% | 65.36% | 9.05% | 0.00% | 5,418.00 | 0.64% |
| 2013 | 25.73% | 6.01% | 61.14% | 7.12% | 0.00% | 4,914.00 | 0.00% |
| 2012 | 14.85% | 3.05% | 73.74% | 6.59% | 0.00% | 4,452.00 | 1.77% |
| 2011 | 14.85% | 14.83% | 64.34% | 0.09% | 0.00% | 4,331.00 | 5.89% |
| 2010 | 23.75% | 10.10% | 56.43% | 0.09% | 0.00% | 4,445.00 | 9.63% |
| 2009 | 33.77% | 6.36% | 53.66% | 0.09% | 0.00% | 4,352.00 | 6.12% |
| 2008 | 30.91% | 3.48% | 54.41% | 0.08% | 0.00% | 4,371.00 | 11.12% |
| 2007 | 34.37% | 10.94% | 54.31% | 0.09% | 0.00% | 4,541.00 | 0.29% |
| 2006 | 27.71% | 9.16% | 63.05% | 0.08% | 0.00% | 4,284.00 | 6.95% |
| 2005 | 29.41% | 9.21% | 57.58% | 0.09% | 0.00% | 4,065.00 | 3.71% |
| 2004 | 23.95% | 13.99% | 61.97% | 0.09% | 0.00% | 4,012.00 | 0.00% |
| 2003 | 16.01% | 3.65% | 80.19% | 0.09% | 0.00% | 3,381.00 | 0.06% |
| Company | Current Price | Change | Date |
|---|---|---|---|
| Abbot Laboratories (ABOT) | Rs 935.61 | 2.67% | Aug 25, 2026 |
| AGP Limited (AGP) | Rs 170.29 | -1.84% | Aug 25, 2026 |
| BF Biosciences Limited (BFBIO) | Rs 134.82 | -0.33% | Aug 25, 2026 |
| Citi Pharma Limited (CPHL) | Rs 76.18 | 0.87% | Aug 25, 2026 |
| Ferozsons Laboratories Limited (FEROZ) | Rs 361.68 | 0.22% | Aug 25, 2026 |
| Glaxosmithkline (GLAXO) | Rs 342.84 | -0.03% | Aug 25, 2026 |
| Glaxo Healthcare Pakistan (GSKCH) | Rs 120.23 | -3.20% | Jan 30, 2023 |
| Haleon Pakistan Limited (HALEON) | Rs 722.00 | -0.41% | Aug 25, 2026 |
| Highnoon Laboratories (HINOON) | Rs 970.39 | -0.83% | Aug 25, 2026 |
| Hoechst Pakistan Limited (HPL) | Rs 4,023.98 | -0.15% | Aug 25, 2026 |
| IBL Healthcare Limited (IBLHL) | Rs 48.30 | 0.75% | Aug 25, 2026 |
| IBL Healthcare Limited (r) (IBLHLR) | Rs 0.00 | 0.00% | Aug 27, 2026 |
| Liven Pharma Limited (LIVEN) | Rs 34.11 | 0.35% | Aug 25, 2026 |
| Liven Pharma Limited (r) (LIVENR) | Rs 0.00 | 0.00% | Aug 27, 2026 |
| Macter International Limited (MACTER) | Rs 273.21 | -0.65% | Aug 25, 2026 |